226 related articles for article (PubMed ID: 2659288)
1. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients.
Rabinad E; Bosch-Perez A
Chemotherapy; 1989; 35 Suppl 1():1-7. PubMed ID: 2659288
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of aztreonam in gram-negative pneumonia versus a therapeutic regimen that includes an aminoglycoside. Spanish Study Group.
Marco V; Gobernado M; Santos M; Rabinad E
Chemotherapy; 1989; 35 Suppl 1():81-8. PubMed ID: 2659295
[TBL] [Abstract][Full Text] [Related]
3. A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
Rivera-Vazquez CR; Ramirez-Ronda CH; Rodriguez JR; Saavedra S
Chemotherapy; 1989; 35 Suppl 1():89-100. PubMed ID: 2659296
[TBL] [Abstract][Full Text] [Related]
4. Aztreonam in the treatment of urinary tract infections: a multicenter trial.
Martelli A; Cortecchia V; Ventriglia L
Chemotherapy; 1989; 35 Suppl 1():8-14. PubMed ID: 2659294
[TBL] [Abstract][Full Text] [Related]
5. Combined aztreonam and gentamicin therapy for pseudomonal lower respiratory tract infections.
Andrews R; Fasoli R; Scoggins WG; Algozzine GJ; Spann RW; Sundaresh KV; Mathers JA; Babb R; Kuppinger M; Cooper B
Clin Ther; 1994; 16(2):236-52. PubMed ID: 8062319
[TBL] [Abstract][Full Text] [Related]
6. Role of aztreonam in lower respiratory tract infections.
Cook JL
Urology; 1988 Jun; 31(6 Suppl):33-6. PubMed ID: 3287748
[TBL] [Abstract][Full Text] [Related]
7. Aztreonam in the treatment of serious gram-negative infections in the elderly.
Deger F; Douchamps J; Freschi E; Thys JP; Nève P; Herchuelz A
Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):22-6. PubMed ID: 3403089
[TBL] [Abstract][Full Text] [Related]
8. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
Scully BE; Neu HC
Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
[TBL] [Abstract][Full Text] [Related]
9. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of low-dose aztreonam in the treatment of moderate to severe infections due to gram-negative bacilli.
Clergeot A; Steru D; Rosset MA; Carbon C
Rev Infect Dis; 1991; 13 Suppl 7():S648-51. PubMed ID: 2068476
[TBL] [Abstract][Full Text] [Related]
11. Gram-negative bacillary pneumonia in the nosocomial setting. Role of aztreonam therapy.
Cook JL
Am J Med; 1990 Mar; 88(3C):34S-37S; discussion 38S-42S. PubMed ID: 2316557
[TBL] [Abstract][Full Text] [Related]
12. Aztreonam: the first monobactam.
Neu HC
Med Clin North Am; 1988 May; 72(3):555-66. PubMed ID: 3280906
[TBL] [Abstract][Full Text] [Related]
13. Aztreonam: worldwide overview of the treatment of patients with gram-negative infections.
Henry SA; Bendush CB
Am J Med; 1985 Feb; 78(2A):57-64. PubMed ID: 3881950
[TBL] [Abstract][Full Text] [Related]
14. The use of aztreonam in serious gram-negative infections.
Smith G; Bunney RG; Farrell ID; Wood MJ
J Antimicrob Chemother; 1988 Feb; 21(2):233-41. PubMed ID: 3283094
[TBL] [Abstract][Full Text] [Related]
15. [Aztreonam treatment of severe infections caused by gram-negative aerobic bacilli].
Peter JD; Jehl F; Froehly S; Dupeyron JP; Monteil H; Rosset MA
Pathol Biol (Paris); 1988 May; 36(5):525-30. PubMed ID: 3043352
[TBL] [Abstract][Full Text] [Related]
16. The clinical use of aztreonam.
Schönwald S; Schoss-Vidensek Z; Car V; Krznar B
Chemotherapy; 1989; 35 Suppl 1():45-8. PubMed ID: 2731450
[TBL] [Abstract][Full Text] [Related]
17. Aztreonam therapy for serious gram-negative bacillary infections.
Cone LA; Woodard DR
Rev Infect Dis; 1985; 7 Suppl 4():S794-802. PubMed ID: 3909339
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of aztreonam in the treatment of serious gram-negative infections in a university hospital in Saudi Arabia.
Fayed DF; Dahmash NS; Saddique AA; Shibl AM
J Chemother; 1992 Jun; 4(3):167-70. PubMed ID: 1517810
[TBL] [Abstract][Full Text] [Related]
19. Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia.
Schentag JJ; Vari AJ; Winslade NE; Swanson DJ; Smith IL; Simons GW; Vigano A
Am J Med; 1985 Feb; 78(2A):34-41. PubMed ID: 3881947
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W
Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
